Quick Answer
Biohaven Ltd. reported Net Income Loss of -$738.82 million for the year ending 2025.
- Biohaven Ltd. showed an increase of +12.7% in Net Income Loss from 2024 to 2025.
- This data is from Biohaven Ltd.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: -$62.12 million | Q2 2021: -$45.42 million | Q3 2021: -$54.37 million | Q1 2022: -$97.03 million | Q2 2022: -$203.29 million | Q3 2022: -$68.85 million | Q1 2023: -$70.49 million | Q2 2023: -$90.35 million | Q3 2023: -$102.57 million | Q1 2024: -$179.50 million | Q2 2024: -$319.77 million | Q3 2024: -$160.30 million | Q1 2025: -$221.68 million | Q2 2025: -$198.15 million | Q3 2025: -$173.44 million.
- Over the full 6 years of available data (2020 to 2025), Biohaven Ltd.'s Net Income Loss has declined by 522.6%.
- Historical annual values: Fiscal year 2025: -$738.82 million | Fiscal year 2024: -$846.42 million | Fiscal year 2023: -$408.17 million | Fiscal year 2022: -$570.28 million | Fiscal year 2021: -$213.80 million | Fiscal year 2020: -$118.67 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: